Technology News and Research

RSS

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Imperial Innovations is pleased to announce the launch of Orthonika, a spinout company from Imperial College London that is developing a novel knee meniscus replacement, MenisciKnit.

4 Aug 2015

Oasmia announces topline results from head-to-head comparison study of Paclical and Abraxane

Oasmia Pharmaceutical AB, developer of a new generation of drugs within human and veterinary oncology, announced today the topline findings from a head-to-head comparison study of its lead human cancer product candidate Paclical and Celgene's Abraxane, which show similar pharmacokinetic (PK) profiles of the two products. The study was conducted in women with metastatic breast cancer.

4 Aug 2015

Syneron Medical's second quarter 2015 revenue up 14% to $73.5 million

Syneron Medical Ltd., a leading global aesthetic device company, today announced financial results for the three month period ended June 30, 2015.

4 Aug 2015

Stress Resilience Training System app for military personnel now available through Apple App Store

The Stress Resilience Training System (SRTS), an app designed to provide resilience training for military personnel by Perceptronics Solutions, Inc., is now available through the Apple App Store for anyone with an iPad.

4 Aug 2015

Northwestern gets $17.5 million NIH grant to invent, develop implantable drug delivery system for HIV prevention

Northwestern Medicine scientists have received a five-year, $17.5 million grant from the National Institutes of Health for an interdisciplinary project that aims to invent, develop and test an implantable drug delivery system to protect high-risk individuals from HIV infection for up to a year at a time.

4 Aug 2015

Penn Medicine devises new approach to develop vaccines against lethal diseases

Researchers at the Perelman School of Medicine at the University of Pennsylvania have devised an entirely new approach to vaccines - creating immunity without vaccination.

4 Aug 2015

BrightFocus announces recipients of 2015 research program grants

BrightFocus Foundation, which funds research worldwide on Alzheimer's disease, glaucoma, and macular degeneration, today announced that its 2015 research program grants have been awarded to 58 scientists in 20 states and 7 foreign countries. Part of an $11 million research investment, the grants reflect the largest annual research funding in the foundation's history.

4 Aug 2015

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

Scientists at The New York Stem Cell Foundation Research Institute successfully designed a revolutionary, high-throughput, robotic platform that automates and standardizes the process of transforming patient samples into stem cells.

4 Aug 2015

New Tel Aviv University study sheds light on precise trigger of deadly melanoma

Skin cancer is the most common of all cancers, and melanoma, which accounts for 2% of skin cancer cases, is responsible for nearly all skin cancer deaths. Melanoma rates in the US have been rising rapidly over the last 30 years, and although scientists have managed to identify key risk factors, melanoma's modus operandi has eluded the world of medical research.

4 Aug 2015

Scientists develop artificial blood vessels that are resistant to blood clot formation

Scientists from ITMO University developed artificial blood vessels that are not susceptible to blood clot formation. The achievement was made possible by a new generation of drug-containing coating applied to the inner surface of the vessel.

4 Aug 2015

New big data collaboration aims to improve care management for diabetes, mental health

Duke-NUS Graduate Medical School Singapore and Holmusk, a global tele-health platform, have recently announced a collaboration to further the potential of big data in healthcare. Big data refers to very large, unstructured and diverse datasets that cannot be managed using conventional methods. In healthcare, big data and analytics allow us to discover patterns that would not be found otherwise, and make predictions about disease. This has the potential to improve care and lower costs.

4 Aug 2015

Exalenz Bioscience, Galectin Therapeutics to use BreathID test to assess GR-MD-O2 efficacy in NASH Cirrhosis patients

Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced a collaboration with Galectin Therapeutics to use the BreathID test to monitor patients in a Phase II study evaluating GR-MD-02.

3 Aug 2015

Encision announces financial results for Q1 fiscal year 2016

Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2016 first quarter that ended June 30, 2015.

3 Aug 2015

Technology News and Research

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Oasmia announces topline results from head-to-head comparison study of Paclical and Abraxane

Syneron Medical's second quarter 2015 revenue up 14% to $73.5 million

Stress Resilience Training System app for military personnel now available through Apple App Store

Northwestern gets $17.5 million NIH grant to invent, develop implantable drug delivery system for HIV prevention

Penn Medicine devises new approach to develop vaccines against lethal diseases

BrightFocus announces recipients of 2015 research program grants

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

New Tel Aviv University study sheds light on precise trigger of deadly melanoma

Scientists develop artificial blood vessels that are resistant to blood clot formation

New big data collaboration aims to improve care management for diabetes, mental health

Exalenz Bioscience, Galectin Therapeutics to use BreathID test to assess GR-MD-O2 efficacy in NASH Cirrhosis patients

Encision announces financial results for Q1 fiscal year 2016

Isis Pharmaceuticals, AstraZeneca to develop antisense therapies for cardiovascular, metabolic, renal diseases

Physically impaired people to compete at Cybathlon 2016

U-M’s Taubman Health Sciences Library reopens as transformed space for learning, teaching

New IMA device could improve diagnosis, treatment of chronic musculoskeletal pain

Embracing new technologies to improve healthcare provision

BGI to hold 10th International Conference on Genomics in October

IDIBELL licenses a tool to Oxford Immunotec to improve efficiency of kidney transplants, prevent graft rejection

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News